Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2015 064 733.5 |
96 | EP file number | EAKZ | 15 74 6995.8 |
86 | WO file number | WAKZ | PCT/US2015/014589 |
97 | EP publication number | EPN | 3102208 |
87 | WO publication number | WPN | 2015120133 |
54 | Designation/title | TI | KRISTALLINES POLYMORPH DER FREIEN BASE VON 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYD |
51 | IPC main class | ICM (ICMV) | C07D 401/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/4439 (2006.01), A61P 1/04 (2006.01), A61P 11/00 (2006.01), A61P 25/28 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Feb 5, 2015 |
96 | EP application date | EAT | Feb 5, 2015 |
86 | WO application date | WAT | Feb 5, 2015 |
43 | Date of first publication | OT | Aug 13, 2015 |
| Date of publication of grant | PET | Jan 13, 2021 |
71/73 | Applicant/owner | INH | Global Blood Therapeutics, Inc., South San Francisco, Calif., US |
72 | Inventor | IN | LI, Zhe, South San Francisco, California 94080, US; PARENT, Stephan D., South San Francisco, California 94080, US; HOUSTON, Travis, South San Francisco, California 94080, US |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461937404 P Feb 7, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461937393 P Feb 7, 2014
|
| Due date | FT FG | Feb 28, 2026 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003102208A1 Searchable text:
EP000003102208A1 Original document:
EP000003102208B1 Searchable text:
EP000003102208B1 Original document:
EP000003102208B2 Searchable text:
EP000003102208B2 Original document:
WO002015120133 Searchable text:
WO002015120133 |
43 | Date of first publication | EVT | Aug 13, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Dec 15, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 18, 2025 (Show all update days)(Hide all update days)- Jan 18, 2025
- Aug 1, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 17.07.2024: changed
- Jun 27, 2024; Jan 18, 2024; Dec 17, 2022; Dec 21, 2021; Dec 2, 2021; Oct 28, 2021; Mar 6, 2021; Mar 2, 2021; Jan 28, 2021; Dec 24, 2020; Jun 25, 2020; Aug 23, 2019; Jul 11, 2019; Mar 15, 2018; Jun 14, 2017
- Historical data not available for this/these date(s)
- Dec 15, 2016
- Date of the first transfer into DPMAregister
|